These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30045399)

  • 1. Contrast Media in Time-Resolved MRA at 3T: A Systematic Quantitative and Qualitative Analysis of Concentration and Dose Effects on Image Parameters in Minipigs.
    Hadizadeh DR; Keil VC; Jost G; Pietsch H; Weibrecht M; Marx C; Willinek W
    Rofo; 2018 Aug; 190(8):747-757. PubMed ID: 30045399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Power Versus Manual Injection in Bolus Shape and Image Quality on Contrast-Enhanced Magnetic Resonance Angiography: An Experimental Study in a Swine Model.
    Tsuboyama T; Jost G; Pietsch H; Tomiyama N
    Invest Radiol; 2017 Sep; 52(9):547-553. PubMed ID: 28448310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Contrast Agent Dose Reduction on Vascular Enhancement and Image Quality in Thoracoabdominal Dynamic 3-Dimensional Magnetic Resonance Angiography: A Systematic Intraindividual Analysis in Pigs.
    Endler CH; Jost G; Pietsch H; Luetkens JA; Keil VC; Willinek WA; Attenberger UI; Hadizadeh DR
    Invest Radiol; 2022 Oct; 57(10):689-695. PubMed ID: 35510876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of injector-based contrast agent administration in time-resolved MRA.
    Budjan J; Attenberger UI; Schoenberg SO; Pietsch H; Jost G
    Eur Radiol; 2018 May; 28(5):2246-2253. PubMed ID: 29218620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.
    Fink C; Puderbach M; Ley S; Plathow C; Bock M; Zuna I; Kauczor HU
    Invest Radiol; 2004 Mar; 39(3):143-8. PubMed ID: 15076006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
    J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraindividual comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso.
    Fink C; Puderbach M; Ley S; Risse F; Kuder TA; Bock M; Thaler J; Plathow C; Kauczor HU
    J Magn Reson Imaging; 2005 Aug; 22(2):286-90. PubMed ID: 16028246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
    Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO
    Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
    Johansson L; Kirchin MA; Ahlström H
    Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
    Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
    Morelli JN; Runge VM; Ai F; Zhang W; Li X; Schmitt P; McNeal G; Miller M; Lennox M; Wusten O; Schoenberg SO; Attenberger UI
    Invest Radiol; 2012 Jun; 47(6):376-82. PubMed ID: 22543971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadobutrol Precedes Gd-DTPA in Abdominal Contrast-Enhanced MRA and MRI: A Prospective, Multicenter, Intraindividual Study.
    Liu X; Li Z; Zhang W; Yang C; Diao Y; Duan T; Fu Y; Ren J; Bin S
    Contrast Media Mol Imaging; 2019; 2019():9738464. PubMed ID: 31866800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography.
    Herborn CU; Lauenstein TC; Ruehm SG; Bosk S; Debatin JF; Goyen M
    Invest Radiol; 2003 Jan; 38(1):27-33. PubMed ID: 12496518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
    Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
    Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
    Schnorr J; Wagner S; Abramjuk C; Wojner I; Schink T; Kroencke TJ; Schellenberger E; Hamm B; Pilgrimm H; Taupitz M
    Invest Radiol; 2004 Sep; 39(9):546-53. PubMed ID: 15308937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.